Helen S Mueller

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Top Venues

Cancer discovery

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy. Cancer discovery (2024)
Yaniv Kazansky, Daniel Cameron, Helen S Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Yasumichi Kuwahara, Romel Somwar, Marc Ladanyi, Rui Qu, Elisa De Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer discovery 14 (6) (2024)
Alyssa M Klein, Lynn Biderman, David Tong, Bita Alaghebandan, Sakina A Plumber, Helen S Mueller, Anne van Vlimmeren, Chen Katz, Carol Prives
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53. Proceedings of the National Academy of Sciences of the United States of America 118 (44) (2021)
Helen S Mueller, Colin E Fowler, Simona Dalin, Enrico Moiso, Tee Udomlumleart, Salil Garg, Michael T Hemann, Jacqueline A Lees
Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel. Proceedings of the National Academy of Sciences of the United States of America 118 (34) (2021)